CUE vs K · rev $9.3M vs P/E 23, $29.03B cap
Cue Biopharma (CUE) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
K does not have a complete income-statement cache yet.
CUE currently screens at market cap $59.5M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the CUE and K stock pages for the full models.
Not investment advice.